Publication | Closed Access

A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transfer

Regenerative MedicineLentiviral Gene TransferMyeloma Bone DiseaseMedicineBone Morphogenic ProteinImmunologyStem-cell TherapyMesenchymal Stem CellStem CellsCell BiologyOsteoporosisNew Xenograft Model